Safety Profile of Anticancer and Immune-Modulating Biotech Drugs Used in a Real World Setting in Campania Region (Italy): BIO-Cam Observational Study

• Main Authors: Cristina Scavone (Author), Liberata Sportiello (Author), Maria G. Sullo (Author), Carmen Ferrajolo (Author), Rosanna Ruggiero (Author), Maurizio Sessa (Author), Pasquale M. Berrino (Author), Gabriella di Mauro (Author), Liberato Berrino (Author), Francesco Rossi (Author), Concetta Rafaniello (Author), Annalisa Capuano (Author), BIO-Cam Group (Author), G. Valentini (Author), M. Romano (Author), A. Lo Schiavo (Author), F. Morgillo (Author), R. Nuzzetti (Author), R. D'Aniello (Author), M. L. Aiezza (Author), E. Bizzarro (Author), A. Dello Stritto (Author), G. Di Renzo (Author), V. Trimarco (Author), V. Valente (Author), M. G. Lombardi (Author), M. Spatarella (Author)
• Format: Book
• Published: Frontiers Media S.A., 2017-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objectives: To investigate the occurrence of adverse events (AEs) in naïve patients receiving biotech drugs.Design: A prospective observational study.Setting: Onco-hematology, Hepato-gastroenterology, Rheumatology, Dermatology, and Neurology Units in Campania Region (Italy).Participants: 775 patient...